July 18, 2023 03:31 PM EDT
Deals
Pharma

Doc­tors with­out Bor­ders asks J&J not to en­force sec­ondary patents for TB drug af­ter gener­ic deal with non­prof­it

Paul Schloesser

Associate Editor

Doc­tors with­out Bor­ders crit­i­cized a deal be­tween John­son & John­son and the Stop TB Part­ner­ship that al­lows the Swiss non­prof­it to man­u­fac­ture and sup­ply gener­ic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times